Cargando…
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
RUNX3, runt-domain transcription factor, is a master regulator of gene expression in major developmental pathways. It acts as a tumor suppressor in many cancers but is oncogenic in certain tumors. We observed upregulation of RUNX3 mRNA and protein expression in nasal-type extranodal natural killer (...
Autores principales: | Selvarajan, V, Osato, M, Nah, G S S, Yan, J, Chung, T-H, Voon, D C-C, Ito, Y, Ham, M F, Salto-Tellez, M, Shimizu, N, Choo, S-N, Fan, S, Chng, W-J, Ng, S-B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629367/ https://www.ncbi.nlm.nih.gov/pubmed/28119527 http://dx.doi.org/10.1038/leu.2017.40 |
Ejemplares similares
-
Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation
por: Date, Yuki, et al.
Publicado: (2020) -
The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
por: Soong, R, et al.
Publicado: (2009) -
RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade
por: Oei, Vincent, et al.
Publicado: (2023) -
RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity
por: Chin, D W L, et al.
Publicado: (2016) -
Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling
por: Spender, Lindsay C, et al.
Publicado: (2014)